Research field (1):
Tumor diagnostics and therapeutics
Papers (21):
Kenta Noda, Yeongjoo Lim, Rei Goto, Shintaro Sengoku, Kota Kodama. Cost-effectiveness comparison between blood biomarkers and conventional tests in Alzheimer's disease diagnosis. Drug discovery today. 2024. 103911-103911
Junko Tanizaki, Hiroaki Kuroda, Toshihide Yokoyama, Makoto Takahama, Hiroyasu Shoda, Atsushi Nakamura, Yoshitaka Kitamura, Nobuaki Mamesaya, Yoshihisa Kadota, Kenji Sawa, et al. Lack of Association of Plasma Levels of Soluble PD-1, PD-L1, and CTLA-4 with Survival for Stage II to IIIA Non-Small Cell Lung Cancer after Complete Resection and Adjuvant Chemotherapy. JTO Clinical and Research Reports. 2023. 100590-100590
Kenta Noda, Yeongjoo Lim, Shintaro Sengoku, Kota Kodama. Global biomarker trends in Alzheimer's research: A bibliometric analysis. Drug discovery today. 2023. 103677-103677
Hisato Kawakami, Yu Sunakawa, Eisuke Inoue, Ryo Matoba, Kenta Noda, Toshiyuki Sato, Chihiro Suminaka, Mami Yamaki, Yasuhiro Sakamoto, Ryohei Kawabata, et al. Soluble programmed cell death ligand 1 predicts prognosis for gastric cancer patients treated with nivolumab: Blood-based biomarker analysis for the DELIVER trial. European Journal of Cancer. 2023. 184. 10-20
Takehiro Hasegawa, Takashi Hato, Toshitsugu Okayama, Kazuho Ikeo, Yoshiaki Miyamoto, Niina Iwanaga, Kohjin Suzuki, Maho Yoshida, Kazuto Yamashita, Saya Yamashita, et al. Th1 cytokine endotype discriminates and predicts severe complications in COVID-19. European cytokine network. 2022. 33. 2. 1-12